Balyasny Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-47,073
Closed -$15.5M 2023
2024
Q4
$15.5M Buy
+47,073
New +$15.5M 0.02% 573
2024
Q1
Sell
-15,730
Closed -$5.08M 1997
2023
Q4
$5.08M Buy
+15,730
New +$5.08M 0.01% 776
2023
Q1
Sell
-67,043
Closed -$28.2M 2218
2022
Q4
$28.2M Buy
+67,043
New +$28.2M 0.08% 276
2022
Q3
Sell
-54,343
Closed -$26.9M 2365
2022
Q2
$26.9M Sell
54,343
-28,464
-34% -$14.1M 0.09% 263
2022
Q1
$46.6M Buy
82,807
+32,082
+63% +$18.1M 0.15% 122
2021
Q4
$38.3M Buy
+50,725
New +$38.3M 0.13% 171
2021
Q3
Sell
-50,518
Closed -$32.5M 1675
2021
Q2
$32.5M Buy
+50,518
New +$32.5M 0.15% 148
2021
Q1
Sell
-19,522
Closed -$11.4M 1574
2020
Q4
$11.4M Buy
19,522
+11,634
+147% +$6.78M 0.06% 364
2020
Q3
$4.07M Sell
7,888
-19,194
-71% -$9.89M 0.03% 536
2020
Q2
$12.2M Buy
+27,082
New +$12.2M 0.11% 255
2018
Q4
Sell
-8,956
Closed -$2.8M 1291
2018
Q3
$2.8M Sell
8,956
-25,133
-74% -$7.87M 0.01% 704
2018
Q2
$9.84M Sell
34,089
-8,324
-20% -$2.4M 0.04% 417
2018
Q1
$10.6M Buy
42,413
+41,355
+3,909% +$10.3M 0.04% 435
2017
Q4
$253K Buy
+1,058
New +$253K ﹤0.01% 1564
2017
Q3
Sell
-1,644
Closed -$372K 1660
2017
Q2
$372K Sell
1,644
-23,566
-93% -$5.33M ﹤0.01% 1074
2017
Q1
$5.03M Buy
25,210
+4,486
+22% +$894K 0.02% 598
2016
Q4
$3.78M Buy
+20,724
New +$3.78M 0.02% 607
2016
Q2
Sell
-1,600
Closed -$219K 990
2016
Q1
$219K Buy
+1,600
New +$219K ﹤0.01% 896
2015
Q4
Sell
-1,612
Closed -$217K 1098
2015
Q3
$217K Buy
+1,612
New +$217K ﹤0.01% 828